SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-057760
Filing Date
2020-05-07
Accepted
2020-05-07 07:51:49
Documents
12
Period of Report
2020-05-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2018871-1_8k.htm   iXBRL 8-K 25062
  Complete submission text file 0001104659-20-057760.txt   196990

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA immu-20200505.xsd EX-101.SCH 3198
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE immu-20200505_lab.xml EX-101.LAB 34591
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE immu-20200505_pre.xml EX-101.PRE 22718
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2018871-1_8k_htm.xml XML 3484
Mailing Address 300 AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address 300 AMERICAN RD MORRIS PLAINS NJ 07950 9736058200
IMMUNOMEDICS INC (Filer) CIK: 0000722830 (see all company filings)

IRS No.: 611009366 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-12104 | Film No.: 20854624
SIC: 2835 In Vitro & In Vivo Diagnostic Substances